Lu, Y., Ma, D., Xu, W., Shao, S., & Yu, X. (2015). Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis. J Diabetes Investig.
Dyfyniad Arddull ChicagoLu, Yu, Delin Ma, Weijie Xu, Shiying Shao, and Xuefeng Yu. "Effect and Cardiovascular Safety of Adding Rosiglitazone to Insulin Therapy in Type 2 Diabetes: A Meta-analysis." J Diabetes Investig 2015.
Dyfyniad MLALu, Yu, et al. "Effect and Cardiovascular Safety of Adding Rosiglitazone to Insulin Therapy in Type 2 Diabetes: A Meta-analysis." J Diabetes Investig 2015.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.